Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswireDec 20 16:30 ET

Express News | Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

ReutersDec 20 16:30 ET

Wells Fargo Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Raises Target Price to $88

Moomoo NewsDec 20 14:35 ET · Ratings

Wells Fargo Remains a Buy on Ultragenyx Pharmaceutical (RARE)

TipRanksDec 20 13:39 ET · Ratings

Evercore Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Maintains Target Price $70

Moomoo NewsDec 20 13:31 ET · Ratings

RARE Submits BLA to the FDA for Sanfilippo Syndrome Gene Therapy

Zacks Dec 20 10:35 ET